Evidence map›Paper›PMID 35588429›Full record

ArticlePloS one2022

Prevalence, incidence, morbidity and mortality rates of COPD in Saudi Arabia: Trends in burden of COPD from 1990 to 2019.

Jaber S Alqahtani

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07106086 (Combined Effect of Scapulothoracic Mobilization With Buteyko Breathing on Pulmonary Parameters Functional Capacity and Balance Among COPD), which is not on this map. Cited by 47 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 3 pooled it
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07106086 nacompletednot on this mapstarted 2024, after this paper: background citation

Combined Effect of Scapulothoracic Mobilization With Buteyko Breathing on Pulmonary Parameters Functional Capacity and Balance Among COPD (Chronic Obstructive Pulmonary Disease) Patients

TypeinterventionalSponsorRashid Latif Medical CollegeRan2024 to 2024Enrolled40ConditionsChronic Obstructive Pulmonary DiseaseArmsScapulothoracic mobilization, Buteyko breathing
3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 3 syntheses or guidelines pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Inhaled Nitric Oxide for Clinical Management of COVID-19: A Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2022
    Pooled it
  4. Trial
  5. Article
  6. Article
  7. The Societal and Economic Burden of COPD in Saudi Arabia.Global journal on quality and safety in healthcare · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Jaber S AlqahtaniDepartment of Respiratory Care, Prince Sultan Military College of Health Sciences, Dammam, Saudi Arabia.ORCID 0000-0003-1795-5092
Prince Sultan University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe available data to determine the chronic obstructive pulmonary disease (COPD) burden in Saudi Arabia are scarce. Therefore, this study closely examines and tracks the trends of the COPD burden in Saudi Arabia from 1990 to 2019 using the dataset of the Global Burden of Disease (GBD) 2019.

methodsThis study used the GBD 2019 dataset to analyse the COPD prevalence, incidence, morbidity and mortality rates in the Saudi Arabian population from 1990 to 2019, stratified by sex and age. The age-standardised rate was used to determine the prevalence, incidence, years of life lost (YLLs), years lived with disability (YLDs), disability-adjusted life years (DALYs) and deaths.

resultsIn 2019, an estimated 434,560.64 people (95% Uncertainty Interval (UI) 396,011.72-473,596.71) had COPD in Saudi Arabia, corresponding to an increase of 329.82% compared with the number of diagnosed people in 1990 [101,104.05 (95% UI 91,334.4-111,223.91)]. The prevalence rate of COPD increased by 49%, from 1,381.26 (1,285.35-1,484.96) cases per 100,000 in 1990 to 2,053.04 (1918.06-2194.29) cases per 100,000 in 2019, and this trend was higher in males than females. The incidence rate of COPD in 2019 was 145.06 (136.62-154.76) new cases per 100,000, representing an increase of 43.4% from the 1990 incidence rate [101.18 (95.27-107.86)]. In 2019, the DALYs rate was 508.15 (95% UI 434.85-581.58) per 100,000 population. This was higher in males than females, with a 14.12% increase among males. In 2019, YLLs contributed to 63.6% of DALYs due to COPD. The death rate due to COPD was 19.6 (95% UI 15.94-23.39) deaths per 100 000 in 2019, indicating a decrease of 41.44% compared with the death rate in 1990 [33.55 deaths per 100 000 (95% UI 25.13-47.69)]. In 2019, COPD deaths accounted for 1.65% (1.39-1.88) of the total of deaths in Saudi Arabia and 57% of all deaths caused by chronic respiratory diseases.

conclusionOver the period 1990-2019, the prevalence and incidence of COPD in Saudi Arabia have been steadily rising. Even though COPD morbidity and death rates have been decreasing, they remain higher in men and older age. The holistic assessment and interventions with careful attention to optimising the community-based primary care management, such as screening for early diagnosis, smoking cessation programs and pulmonary rehabilitation, are likely to be the most successful strategies to reduce the burden of COPD in Saudi Arabia.

Indexed as

Global Burden of DiseasePulmonary Disease, Chronic ObstructiveFemaleGlobal HealthHumansIncidenceMalePrevalenceQuality-Adjusted Life YearsRisk FactorsSaudi Arabia

Identifiers

PMID35588429
PMCPMC9119447
OpenAlexW4280509802

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.